Feasibility, reproducibility, and reliability for the T2 * iron evaluation at 3 T in comparison with 1.5 T

Magnetic Resonance in Medicine

Volumn 68, Issue 2, 2012, Pages 543-551

  Meloni, Antonella ^a   Positano, Vincenzo ^a   Keilberg, Petra ^a   De Marchi, Daniele ^a   Pepe, Pasquale ^b   Zuccarelli, Angelo ^c   Campisi, Saveria ^d   Romeo, Maria Antonietta ^e   Casini, Tommaso ^f   Bitti, Pier Paolo ^g   Gerardi, Calogera ^h   Lai, Maria Eliana ⁱ   Piraino, Basilia ^j   Giuffrida, Gaetano ^k   Secchi, Giuseppina ^l   Midiri, Massimo ^m   Lombardi, Massimo ^a   Pepe, Alessia ^a  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c Ospedale Civile   (Italy)

^d UOS Talassemia   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

^g Servizio Immunoematologia e Medicina Trasfusionale   (Italy)

^h Azienda Ospedaliera Ospedali Civili Riuniti di Sciacca   (Italy)

ⁱ Osp Regionale per le Microcitemie   (Italy)

^j UNIVERSITY OF MESSINA   (Italy)

^k Ospedale Ferrarotto   (Italy)

^l Servizio Trasfusionale   (Italy)

^m UNIVERSITY OF PALERMO   (Italy)

more..

Author keywords

3 T; heart; iron overload; liver

Indexed keywords

DIAGNOSIS; IMAGE SEGMENTATION; IRON; LIVER; MAGNETIC RESONANCE IMAGING; RELIABILITY;

CONVERSION FORMULAS; CORRECTION FACTORS; HEALTHY SUBJECTS; IRON OVERLOADS; LINEAR RELATIONSHIPS; REGION OF INTEREST; REPRODUCIBILITIES; SUSCEPTIBILITY ARTIFACTS;

HEART;

IRON;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HEART; HEART MUSCLE; HEART VENTRICLE SEPTUM; HUMAN; IRON OVERLOAD; LIVER; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; RELIABILITY; REPRODUCIBILITY; TRANSFUSION;

EID: 84863835374     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.23236     Document Type: Article

References (34)

1. Maggio A, Capra M, Pepe A, Mancuso L, Cracolici E, Vitabile S, Rigano P, Cassara F, Midiri M,. A critical review of non invasive procedures for the evaluation of body iron burden in thalassemia major patients. Pediatr Endocrinol Rev 2008; 6 (suppl 1): 193-203.
2. Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A,. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004; 89: 1187-1193. (Pubitemid 39390442)
3. Porter JB, Davis BA,. Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. Best Pract Res Clin Haematol 2002; 15: 329-368.
4. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ,. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008; 10: 42.
5. Cogliandro T, Derchi G, Mancuso L, Mayer MC, Pannone B, Pepe A, Pili M, Bina P, Cianciulli P, De Sanctis V, Maggio A,. Guideline recommendations for heart complications in thalassemia major. J Cardiovasc Med (Hagerstown) 2008; 9: 515-525. (Pubitemid 351521635)
6. Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ,. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica 2006; 91: 1388-1391. (Pubitemid 44569814)
7. Ramazzotti A, Pepe A, Positano V, Rossi G, De Marchi D, Brizi MG, Luciani A, Midiri M, Sallustio G, Valeri G, Caruso V, Centra M, Cianciulli P, De Sanctis V, Maggio A, Lombardi M,. Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron. J Magn Reson Imaging 2009; 30: 62-68.
8. Yablonskiy DA, Haacke EM,. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn Reson Med 1994; 32: 749-763. (Pubitemid 24371176)
9. Gati JS, Menon RS, Ugurbil K, Rutt BK,. Experimental determination of the BOLD field strength dependence in vessels and tissue. Magn Reson Med 1997; 38: 296-302. (Pubitemid 27328259)
10. Tumkur S, Vu A, Li L, Prasad PV,. Evaluation of intrarenal oxygenation at 3.0 T using 3-dimensional multiple gradient-recalled echo sequence. Invest Radiol 2006; 41: 181-184. (Pubitemid 44406216)
11. Storey P, Thompson AA, Carqueville CL, Wood JC, de Freitas RA, Rigsby CK,. R2* imaging of transfusional iron burden at 3T and comparison with 1.5T. J Magn Reson Imaging 2007; 25: 540-547. (Pubitemid 46355416)
12. Guo H, Au WY, Cheung JS, Kim D, Jensen JH, Khong PL, Chan Q, Chan KC, Tosti C, Tang H, Brown TR, Lam WW, Ha SY, Brittenham GM, Wu EX,. Myocardial T2 quantitation in patients with iron overload at 3 Tesla. J Magn Reson Imaging 2009; 30: 394-400.
13. Pepe A, Positano V, Santarelli F, Sorrentino F, Cracolici E, De Marchi D, Maggio A, Midiri M, Landini L, Lombardi M,. Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload. J Magn Reson Imaging 2006; 23: 662-668.
14. Positano V, Pepe A, Santarelli MF, Scattini B, De Marchi D, Ramazzotti A, Forni G, Borgna-Pignatti C, Lai ME, Midiri M, Maggio A, Lombardi M, Landini L,. Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts. NMR Biomed 2007; 20: 578-590. (Pubitemid 47496898)
15. Positano V, Pepe A, Santarelli MF, Ramazzotti A, Meloni A, De Marchi D, Favilli B, Cracolici E, Midiri M, Spasiano A, Lombardi M, Landini L,. Multislice multiecho T2* cardiac magnetic resonance for the detection of heterogeneous myocardial iron distribution in thalassaemia patients. NMR Biomed 2009; 22: 707-715.
16. Meloni A, Ramazzotti A, Positano V, Salvatori C, Mangione M, Marcheschi P, Favilli B, De Marchi D, Prato S, Pepe A, Sallustio G, Centra M, Santarelli MF, Lombardi M, Landini L,. Evaluation of a web-based network for reproducible T2* MRI assessment of iron overload in thalassemia. Int J Med Inform 2009; 78: 503-512.
17. Meloni A, Luciani A, Positano V, De Marchi D, Valeri G, Restaino G, Cracolici E, Caruso V, Dell'amico MC, Favilli B, Lombardi M, Pepe A,. Single region of interest versus multislice T2* MRI approach for the quantification of hepatic iron overload. J Magn Reson Imaging 2011; 33: 348-355.
18. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS,. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539-542. (Pubitemid 34262671)
19. *. Eur J Haematol 2006; 76: 183-192.
20. Positano V, Salani B, Pepe A, Santarelli MF, De Marchi D, Ramazzotti A, Favilli B, Cracolici E, Midiri M, Cianciulli P, Lombardi M, Landini L,. Improved T2* assessment in liver iron overload by magnetic resonance imaging. Magn Reson Imaging 2009; 27: 188-197.
21. * and field inhomogeneity maps in the human heart at 1.5 T. Magn Reson Med 1998; 39: 988-998. (Pubitemid 28237758)
22. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD,. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005; 106: 1460-1465. (Pubitemid 41129616)
23. *) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22: 2171-2179. (Pubitemid 33139463)
24. Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, Pennell DJ,. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003; 18: 33-39. (Pubitemid 36791266)
25. Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, Giardini C, Galimberti M, Polchi P, Lucarelli G,. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 2000; 343: 327-331. (Pubitemid 30616698)
26. Wood JC, Ghugre N,. Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases. Hemoglobin 2008; 32: 85-96. (Pubitemid 351264532)
27. O'Regan DP, Callaghan MF, Fitzpatrick J, Naoumova RP, Hajnal JV, Schmitz SA,. Cardiac T2* and lipid measurement at 3.0 T-initial experience. Eur Radiol 2008; 18: 800-805.
28. Hernando D, Hines CD, Reeder SB,. R2* estimation in the presence of fat and macroscopic B0 field variations. In: Proceedings of International Society for Magnetic Resonance in Medicine, Montreal, Vol. 19; 2011. p 2691.
29. Olson LJ, Edwards WD, McCall JT, Ilstrup DM, Gersh BJ,. Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. J Am Coll Cardiol 1987; 10: 1239-1243. (Pubitemid 18004674)
30. Ambu R, Crisponi G, Sciot R, Van Eyken P, Parodo G, Iannelli S, Marongiu F, Silvagni R, Nurchi V, Costa V, et al. Uneven hepatic iron and phosphorus distribution in beta-thalassemia. J Hepatol 1995; 23: 544-549.
31. *, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation 2005; 112: 535-543. (Pubitemid 41060794)
32. Ghugre NR, Storey P, Rigsby CK, Thompson AA, Carqueville CL, Coates TD, Wood JC,. Multi-field behavior of Relaxivity in an iron-rich environment. In: Proceedings of International Society for Magnetic Resonance in Medicine, Toronto, Vol. 16; 2008. p 644.
33. Positano V, Meloni A, Pepe A, Santarelli M, Marchi D, Menichetti L, Dell'Amico C, Favilli B, Milanesi M, Valeri G, Natale L, Tassi C, Casini T, Landini L, Lombardi M,. Cramer-Rao lower bounds for precision in T2* assessment for myocardial iron overload measurements by T2* multi-echo CMR. J Cardiovasc Magn Reson 2010; 12v (suppl 1): P275.
34. Reeder SB, Bice EK, Yu H, Hernando D, Pineda AR,. On the performance of T(2)* correction methods for quantification of hepatic fat content. Magn Reson Med, in press; DOI 10.1002/mrm.23016.